No Data
No Data
Further Upside For Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHSE:688566) Shares Could Introduce Price Risks After 38% Bounce
Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHSE:688566) Surges 8.5%; Private Companies Who Own 35% Shares Profited Along With Insiders
jiangsu jibeier pharmaceutical co., ltd. (688566.SH): The company remains the only enterprise domestically and internationally capable of producing Liquejunn tablets.
格隆汇September 25th | jiangsu jibeier pharmaceutical co., ltd. (688566.SH) stated at an investor relations event that the company has conducted systematic research on the method of Licocjun detection, optimizing processes, improving quality, researching methodology, etc. The company has comprehensively applied for national invention patents and obtained authorization, forming multiple levels of technological barriers and protection for the product, ensuring the quality and clinical efficacy of Licocjun tablets. At the same time, the company has applied for patent protection and obtained the "A crystal form and preparation method, application of Licocjun" and "B crystal form and preparation method, application of Licocjun" patents from the State Intellectual Property Office for the preparation method and application of Licocjun crystals.
Jibeier Pharmaceutical Gets Nod to Market Lomefloxacin Hydrochloride
Gibbel 2024 Semi-Annual Report
Gibbel 2024 Semi-Annual Report Summary
No Data
No Data